IL-6 receptor-mediated lung Th2 cytokine networking in silica-induced pulmonary fibrosis

Shambhoo Sharan Tripathi1, Vani Mishra, Mamta Shukla

  • 1Immunobiology Division, Indian Institute of Toxicology Research, Mahatma Gandhi Marg, Lucknow, 226001, India.

Insights

Silica exposure causes lung inflammation and fibrosis by increasing Th2 cytokines and signal molecules like Stat3 and Socs3. Interleukin-6 receptor alpha (IL-6Rα) mediates these effects in pulmonary silicosis.

Area of Science:

  • Pulmonary immunology
  • Toxicology
  • Molecular biology

Background:

  • Pulmonary silicosis is a fatal lung disease driven by inflammation and cytokine activity.
  • The role of signal transduction pathways and interleukin-6 receptor alpha (IL-6Rα) in silicosis pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the expression of signal transducers and activator of transcription (Stat3), suppressor of cytokine signalling 3 (Socs3), and inflammatory cytokines in silica-exposed mice.
  • To determine the relationship between these molecules and IL-6Rα in the context of pulmonary silicosis.

Main Methods:

  • Utilized silica-exposed and IL-6Rα gene knockdown Balb/c mice models.
  • Assessed lung function via plethysmography, mRNA expression via qRT-PCR, and lung architecture via histopathology.
  • Quantified Th2 cytokines in broncho-alveolar lavage fluid (ELISA) and hydroxyproline in lung tissue (colorimetry).

Main Results:

  • Silica exposure led to lung fibrosis, inflammation, and increased airway resistance.
  • Heightened expression of Th2 cytokines (IL-4, IL-5, IL-6) and signal molecules (Stat3, Socs3) was observed in silica-exposed mice.
  • Silencing IL-6Rα significantly downregulated Th2 cytokines and signal molecules, indicating IL-6Rα mediates these responses.

Conclusions:

  • Hypermorphic expression of Th2 cytokines and signal molecules in silica-induced pulmonary silicosis is mediated through IL-6Rα.
  • IL-6Rα plays a critical role in regulating inflammatory responses and fibrotic processes in silicosis.
  • Targeting IL-6Rα may offer a therapeutic strategy for managing pulmonary silicosis.

Related Concept Videos